Pan-Malaria Transmission-Blocking Vaccine AnAPN1
NCT05905432
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
DRUG:
Vaccine AnAPN1
Sponsor
Centre de Recherche Médicale de Lambaréné
Collaborators
[object Object]